- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Aromatase Inhibitors
Total 64385 results
-
Cairo UniversityUnknown
-
PfizerTerminatedEarly Breast Cancer (Phase 2) | Advanced Breast Cancer (Phase 1b)Spain, Sweden, Italy, Belgium
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)WithdrawnBreast CancerUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)Withdrawn
-
Dr. Reddy's Laboratories LimitedCompleted
-
Novartis PharmaceuticalsRoche - Prof. Dr. Jens Huober et al.TerminatedMetastatic Breast CancerGermany
-
Korean Breast Cancer Study GroupUnknownBreast CancerKorea, Republic of
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCActive, not recruitingBreast Cancer | Non Small Cell Lung CancerUnited States, Spain, France, Belgium, Italy, Taiwan, Turkey
-
Latin American Cooperative Oncology GroupPfizerCompleted
-
Baylor Breast Care CenterGlaxoSmithKline; Translational Breast Cancer Research ConsortiumActive, not recruitingBreast CancerUnited States
-
PfizerCompletedBreast CancerKorea, Republic of, United States, Spain, Germany, Ireland, Hungary, Canada, France, Italy, Russian Federation, South Africa, Ukraine
-
PfizerTerminated
-
GlaxoSmithKlineTerminatedNeoplasms, BreastUnited States, Belgium, United Kingdom, Germany, Russian Federation, Italy, France
-
University of Alabama at BirminghamNovartis Pharmaceuticals; Tracon Pharmaceuticals Inc.Completed
-
University of California, San FranciscoNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer CenterCompleted
-
Institut Català d'OncologiaUnknown
-
Bristol-Myers SquibbCompletedCancer | Breast CancerBelgium, United States, Spain, France, Germany, Australia, Canada, Puerto Rico
-
Yale UniversityNovartis; Genentech, Inc.TerminatedBreast Cancer | Hormone-Sensitive Breast CancerUnited States
-
Assiut UniversityRecruitingInfertility, FemaleEgypt
-
Swiss Group for Clinical Cancer ResearchCompletedBreast CancerSwitzerland
-
Merck Sharp & Dohme LLCCompleted
-
AstraZenecaCompletedPuberty, PrecociousUnited States, Canada, Russian Federation, France, India, United Kingdom
-
NovartisCompleted
-
Merrimack PharmaceuticalsCompletedHer2 Negative Breast Cancer PatientsUnited States, Spain, Canada, Germany, Russian Federation
-
AstraZenecaCompletedFGFR Inhibition, Pharmacokinetics, Biomarkers | ER+ Breast CancerCzech Republic, Italy, United Kingdom, Hungary, Germany, Romania, Belgium, France
-
Novartis Healthcare A/SCompleted
-
PfizerTerminatedBreast NeoplasmsUnited States, Canada, Netherlands, Brazil, Belgium, United Kingdom, Argentina, Italy, Sweden
-
Nemours Children's ClinicEMD Serono; AstraZeneca; Genentech, Inc.Completed
-
AstraZenecaCompleted
-
Fudan UniversityUnknown
-
University of KansasCompletedBreast CancerUnited States
-
Intarcia TherapeuticsCompletedBreast Neoplasms | Neoplasms, Hormone-dependentUnited States, Canada, Russian Federation, Ukraine
-
South Egypt Cancer InstituteRecruitingLung Diseases | Pain, AcuteEgypt
-
M.D. Anderson Cancer CenterNovartisActive, not recruiting
-
Jonsson Comprehensive Cancer CenterBayer; Translational Research in Oncology-U.S. Inc. (TRIO-US)TerminatedStage I Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative and other conditionsUnited States
-
Haihe Biopharma Co., Ltd.Not yet recruiting
-
PfizerArvinas Estrogen Receptor, Inc.Active, not recruitingBreast CancerSpain, United States, China, Japan, Australia, Italy, Switzerland, Hungary, Brazil, Slovakia
-
Hoffmann-La RocheCompletedEarly Breast CancerSpain, Korea, Republic of, Australia, Taiwan, Ukraine, Poland, Russian Federation, United States, Germany, Brazil, Hungary
-
Syndax PharmaceuticalsCompletedBreast Cancer | Estrogen Receptor Positive Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterTerminatedEndocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-Sensitive Metastatic Breast CancerHormone-sensitive Metastatic Breast CancerUnited States
-
Onconova Therapeutics, Inc.RecruitingEndometrioid Endometrial CancerUnited States
-
Assiut UniversityNot yet recruiting
-
Queen Mary Hospital, Hong KongQueen Elizabeth Hospital, Hong Kong; Prince of Wales Hospital, Shatin, Hong... and other collaboratorsRecruiting
-
Beta Pharma (Suzhou) Co., Ltd.RecruitingAdvanced Solid Tumor | HR+/HER2- Breast CancerChina
-
Arvinas Inc.PfizerActive, not recruitingBreast CancerUnited States, Spain, Germany, Georgia
-
Rovi Pharmaceuticals LaboratoriesActive, not recruiting
-
Brigham and Women's HospitalJohns Hopkins University; National Institute on Aging (NIA); Rutgers UniversityActive, not recruiting
-
Spanish Breast Cancer Research GroupAstraZenecaTerminated